Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation

Lignende værker

• Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34(+) cell dose
  af: Pulsipher, Michael A., et al.
  Udgivet: (2009)
• Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program
  af: Pulsipher, Michael A., et al.
  Udgivet: (2013)
• Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management
  af: Seftel, Matthew D., et al.
  Udgivet: (2020)
• The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report from the Related Donor Safety Study (RDSafe)
  af: Pulsipher, Michael A., et al.
  Udgivet: (2018)
• Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study
  af: Seftel, Matthew D., et al.
  Udgivet: (2021)